Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Neurol.

Sec. Stroke

Volume 16 - 2025 | doi: 10.3389/fneur.2025.1660604

Somatic Mutations in Angiogenesis-Related Pathways and RNA Polymerase II Activity in Sporadic Brain Arteriovenous Malformations

Provisionally accepted
REBECA  PÉREZ ALFAYATEREBECA PÉREZ ALFAYATE1,2*Vanesa  García-BarberánVanesa García-Barberán2,3Isabel  Casado-FariñasIsabel Casado-Fariñas4Desiré  Hernández-MartínezDesiré Hernández-Martínez4Maria  Elena Gomez del PulgarMaria Elena Gomez del Pulgar2,3Juan  Pablo Castaño-MontoyaJuan Pablo Castaño-Montoya1Pedro  Pérez SeguraPedro Pérez Segura2,5Santiago  Cabezas-CamareroSantiago Cabezas-Camarero2,6
  • 1Neurosurgery Department, Hospital Clinico San Carlos, Madrid, Spain
  • 2Instituto de Investigacion Sanitaria Hospital Clinico San Carlos, Madrid, Spain
  • 3Hospital Clinico San Carlos Laboratorio de Oncologia Molecular, Madrid, Spain
  • 4Pathology Department, Hospital Clinico San Carlos, Madrid, Spain
  • 5Medical Oncology Department, Hospital Clinico San Carlos, Madrid, Spain
  • 6Medical Oncology Department, Hospital Clinico San Carlos, Madrid, Spain

The final, formatted version of the article will be published soon.

Background: Sporadic brain arteriovenous malformations (bAVMs) are rare vascular anomalies characterized by abnormal angiogenesis and direct arteriovenous shunting. While the VEGF pathway is well studied, the genetic landscape contributing to angiogenic dysregulation remains poorly defined. We aimed to characterize the mutational profile of resected bAVMs using a pan-cancer next-generation sequencing panel, with particular focus on angiogenesis-associated pathways and RNA Polymerase II activity. Methods: A descriptive analysis of clinical and molecular characteristics was conducted In formalin-fixed, paraffin-embedded tissue from the bAVM nidus. DNA was extracted and sequenced using the Oncomine Tumor Mutational Load Assay, covering 409 cancer-related genes. Variants were filtered for pathogenicity, allele frequency, and functional relevance. Results: Thirteen sporadic bAVMs were retrospectively analyzed. Twelve pathogenic variants were detected in 7/13 (54%) patients , with variant allele frequencies ranging from 3.61% to 50.61%. Most mutations clustered within angiogenesis-related pathways (PI3K/AKT/mTOR, RAS/MAPK), DNA repair mechanisms, and transcriptional regulators of RNA Polymerase II. Notably, six mutations involved genes with known functional links to RNA Pol II activity. These findings suggest a converging role for transcriptional dysregulation and vascular remodeling in bAVM pathogenesis. Conclusions: This study proposes a novel hypothesis implicating RNA Polymerase II-mediated transcription in the aberrant angiogenesis of bAVMs. While KRAS mutations were detected at low frequency and allele burden, other genetic alterations in DNA repair and transcriptional machinery may drive or sustain vascular instability. Further functional validation is warranted to clarify their pathogenic role and therapeutic potential. Keywords: brain arteriovenous malformation; angiogenesis; somatic mutation; RNA Polymerase II; PI3K pathway; DNA repair; next-generation sequencing.

Keywords: Brain arteriovenous malformation, Angiogenesis, somatic mutation, RNA Polymerase II, PI3K pathway, DNA Repair, Next-generation sequencing, Intracranial Arteriovenous Malformations

Received: 06 Jul 2025; Accepted: 03 Sep 2025.

Copyright: © 2025 PÉREZ ALFAYATE, García-Barberán, Casado-Fariñas, Hernández-Martínez, Gomez del Pulgar, Castaño-Montoya, Pérez Segura and Cabezas-Camarero. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: REBECA PÉREZ ALFAYATE, Neurosurgery Department, Hospital Clinico San Carlos, Madrid, Spain

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.